Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Active not recruiting 3Withdrawn 2Completed 2Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Wilms Tumor 1Sarcoma, Kaposi 1Sarcoma 1Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1Liposarcoma 1Hodgkin Disease 1Her2-negative Metastatic Breast Cancer 1Carcinoma, Ovarian Epithelial 1Acquired Immunodeficiency Syndrome 1AIDS-related Kaposi sarcoma 1

Interventions

anlotinib 3Injections 3Doxorubicin 3toripalimab 1spartalizumab 1penpulimab 1pemigatinib 1pazopanib 1montelukast 1liposomal doxorubicin 1eribulin 1chlorhexidine gluconate 1camrelizumab 1bexmarilimab 1apatinib 1X-Rays 1Trabectedin 1Temozolomide 1Tablets 1Surgical Procedures, Operative 1Sodium Chloride 1Radiotherapy 1Proton Therapy 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Neoadjuvant Therapy 1Negative-Pressure Wound Therapy 1KP 1339 1Ipilimumab 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Sarcoma × liposomal doxorubicin × Clear all
NCT06694324 2024-11-19

First-line Treatment of Advanced/unresectable DDLPS

Fudan University

Phase 2 Not yet recruiting
49 enrolled
Sarcoma

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡